HB Wealth Management LLC Grows Stake in Humana Inc. (NYSE:HUM)

HB Wealth Management LLC lifted its stake in shares of Humana Inc. (NYSE:HUM) by 12.0% in the 1st quarter, HoldingsChannel reports. The firm owned 3,776 shares of the insurance provider’s stock after buying an additional 406 shares during the quarter. HB Wealth Management LLC’s holdings in Humana were worth $999,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of HUM. Dodge & Cox grew its position in Humana by 106.7% during the fourth quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider’s stock worth $2,587,345,000 after buying an additional 5,264,045 shares in the last quarter. Pzena Investment Management LLC grew its position in Humana by 6.1% during the first quarter. Pzena Investment Management LLC now owns 3,828,923 shares of the insurance provider’s stock valued at $1,013,133,000 after acquiring an additional 219,541 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Humana by 2.3% in the fourth quarter. Geode Capital Management LLC now owns 2,883,614 shares of the insurance provider’s stock worth $729,658,000 after buying an additional 63,562 shares during the period. Invesco Ltd. lifted its position in Humana by 29.8% in the fourth quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider’s stock valued at $608,348,000 after purchasing an additional 550,692 shares during the last quarter. Finally, T. Rowe Price Investment Management Inc. raised its holdings in Humana by 11.1% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 1,605,771 shares of the insurance provider’s stock valued at $407,401,000 after buying an additional 160,952 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Trading Up 0.5%

Shares of HUM stock opened at $232.59 on Wednesday. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.71. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $406.09. The stock has a market capitalization of $28.07 billion, a P/E ratio of 16.45, a P/E/G ratio of 1.58 and a beta of 0.44. The firm’s 50 day moving average is $233.79 and its 200 day moving average is $255.68.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, beating the consensus estimate of $10.07 by $1.51. Humana had a return on equity of 14.47% and a net margin of 1.42%. The firm had revenue of $32.11 billion for the quarter, compared to analysts’ expectations of $32 billion. During the same period in the prior year, the firm earned $7.23 EPS. The company’s revenue was up 8.4% compared to the same quarter last year. Research analysts expect that Humana Inc. will post 16.47 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Robert W. Baird dropped their target price on shares of Humana from $300.00 to $297.00 and set a “neutral” rating for the company in a research report on Friday, July 25th. Bank of America cut their target price on Humana from $320.00 to $260.00 and set a “neutral” rating on the stock in a research note on Tuesday, June 17th. Cantor Fitzgerald restated a “neutral” rating and set a $290.00 price target on shares of Humana in a report on Thursday, May 1st. Wells Fargo & Company set a $348.00 price target on shares of Humana in a research note on Friday, July 18th. Finally, Barclays set a $268.00 price objective on shares of Humana and gave the company an “equal weight” rating in a research report on Thursday, June 12th. Sixteen research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $282.43.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.